Progyny PGNY
NASDAQ PGNY
$25.23 +0.38 (+1.53%)
At close: Oct 2, 2026 · 4:00 PM EDT

Progyny (PGNY) Gains from Sales and Divestitures (2019 - 2026)

Updated

Progyny's Gains from Sales and Divestitures was -$528,000 in Q2 2026.

Analysis

Progyny (PGNY) Gains from Sales and Divestitures (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Progyny's Gains from Sales and Divestitures was -$601,000 through Jun 30, 2026; for FY2025, it was -$100,000.

  • In earlier years, Gains from Sales and Divestitures was -$1.41 million in FY2024.
  • The Q2 2026 figure marks the lowest quarterly Gains from Sales and Divestitures since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 93.08 Bn 92.52 Bn -
2 Natera 58.93 Bn 54.61 Bn 485.19 Mn
3 Quest Diagnostics 25.75 Bn 24.18 Bn 1.03 Bn
4 Labcorp Holdings 24.96 Bn 22.73 Bn 1.11 Bn
5 Guardant Health 23.76 Bn 19.82 Bn 219.03 Mn
6 Tenet Healthcare 20.83 Bn 11.98 Bn -
7 Tempus AI 13.43 Bn 10.46 Bn 246.50 Mn
8 BrightSpring Health Services 11.90 Bn 10.24 Bn 492.75 Mn
9 Encompass Health 11.82 Bn 12.29 Bn -
10 Progyny 1.95 Bn 835.22 Mn 89.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -528,000.00
Mar 31, 2026 -52,000.00
Dec 31, 2025 -21,000.00
Mar 31, 2025 -79,000.00
Dec 31, 2024 -1.41 Mn
Mar 31, 2019 -1,000.00
API Access

Progyny Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=PGNY&period=max&api_key=YOUR_API_KEY